Advancements in the Pharmaceutical Oncology - PowerPoint PPT Presentation

About This Presentation
Title:

Advancements in the Pharmaceutical Oncology

Description:

Cancer therapy continues to progress. Efficient prevention, faster detection, a greater understanding of the causing genetic abnormalities, and the discovery of novel medicines all contribute to a drop in cancer mortality year in and year out. Conversely, certain malignancies continue to be resistant to all therapy despite increasing accomplishments. There is a major medical need to get better medicines to these patients more rapidly and efficiently in terms of time, cost, and the likelihood of success. – PowerPoint PPT presentation

Number of Views:2

less

Transcript and Presenter's Notes

Title: Advancements in the Pharmaceutical Oncology


1
Advancements in the Pharmaceutical Oncology
2
  • About Pinnacle Lifescience
  • Pinnacle Life Science is a 100 subsidiary of
    Indias most trusted pharmaceutical company Aarti
    Drugs Ltd (ADL) and forms part of 1.5 billion
    conglomerate of the esteemed Aarti Group of
    Industries.
  • With 35 years of healthcare commitment through
    Aarti Drugs, Pinnacle has made its presence in
    nearly 90 countries. Treading carefully on the
    path of efficient healthcare, the
    state-of-the-art manufacturing facility is
    designed to produce formulations that meet
    international quality standards and stringent
    regulatory compliances to trade beyond borders.
  • With significant expansion in RD, Manufacturing
    Marketing capabilities, we are poised for an
    accelerated growth.

3
  • Advancements in the Pharmaceutical Oncology
  • Cancer therapy continues to progress. Efficient
    prevention, faster detection, a greater
    understanding of the causing genetic
    abnormalities, and the discovery of novel
    medicines all contribute to a drop in cancer
    mortality year in and year out. Conversely,
    certain malignancies continue to be resistant to
    all therapy despite increasing accomplishments.
    There is a major medical need to get better
    medicines to these patients more rapidly and
    efficiently in terms of time, cost, and the
    likelihood of success. Oncology clinical drug
    development innovation is required to allow more
    effective and efficient development of novel
    cancer therapeutics and provide patients
    especially those with rare cancers- with access
    to new medications much sooner.

4
  • Advancements in the Pharmaceutical Oncology
  • However, beginning in the late 1980s, there was a
    surge in the knowledge of the molecular defects
    that produce and perpetuate the tumours distinct
    traits. This molecular knowledge has led to the
    creation of targeted medicines and therapeutic
    interventions, each tailored to a certain kind of
    genetic abnormality.

5
  • Advancements in the Pharmaceutical Oncology
  • IPrecision medicine in cancer began with the
    discovery of targeted medicines. This medical
    strategy entails identifying the molecular
    lesions present in a tumour and then choosing
    therapies targeting these lesions precisely.
    Precision medicine strives to provide cancer
    patients with the most suitable treatment the
    right drug, for the right patient, at the right
    time, and the right dose. This is especially
    relevant since individuals with comparable tumour
    form and function, known as tumour histology,
    may have patient subpopulations due to various
    genetic abnormalities in their tumours.
  • Poverty, late and inadequate cancer diagnosis,
    and a lack of medical coverage have been
    identified as the top three severe obstacles
    cancer patients face in various situations.

6
  • Advancements in the Pharmaceutical Oncology
  • Scientific improvements must be linked with
    dynamic public-private partnerships and a clear
    explanation of our aims to overcome the
    challenges in our path to providing sustainable
    cancer treatment to all. To fully embrace
    value-based medicine, we must change our focus
    from paying per pill to long-term benefits
    across a patients lifetime benefits to the
    patient, the healthcare system, and society. It
    also entails breaking down divisions in
    healthcare budgets and exploring ways to share
    expenses and savings. This means, for example,
    that if a pharmaceutical minimises
    post-chemotherapy hospitalisations, we have the
    freedom to support this treatment not just from
    the pharmacy budget but also from the hospital
    budget savings associated with this favourable
    outcome.

7
  • Advancements in the Pharmaceutical Oncology
  • Corporations may find it necessary to raise
    resources for educational initiatives to ensure
    that all stakeholders know better about novel
    financing and reimbursement methods that will
    ensure medications reach the patients who need
    them. We can determine which funding options are
    appropriate based on the disease area and
    demographic segment by working together. Finally,
    authorities throughout the globe must transform
    the way they think about and communicate about
    cancer to effectively assist patients and their
    families. Cancer research spending rates differ
    over the world, especially among underdeveloped
    countries.
  • More information https//www.pinnaclelifescience.
    com/2021/12/03/advancements-in-the-pharmaceutical-
    oncology/

8
Contact Us
Address Mahendra Industrial Estate, Ground
Floor, Plot No. 109D, Road No 29, Sion(E)
Mumbai-400022, India. Phone No  91 (22)
24019025 Email export.pinnacle_at_aartidrugs.com Sit
e www.pinnaclelifescience.com
9
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com